Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.
Press releases published on August 27, 2025
Alpha Tau to Participate in Five September Investor Conferences
GlobeNewswire
·
August 27, 2025
JERUSALEM, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present and meet …
Disc Medicine to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 27, 2025
HOUSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …
Commure Ambient AI Scores High Marks in KLAS First Look Report for Automating Provider Documentation & RCM
GlobeNewswire
·
August 27, 2025
MOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Commure, a leading healthcare technology company, today announced that its Commure Ambient AI solution has been spotlighted in a 2025 KLAS First Look Report for its ability to dramatically reduce …
Allogene Therapeutics Announces Participation in Upcoming Investor Conference
GlobeNewswire
·
August 27, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …
Lexicon Pharmaceuticals to Participate at Two Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
THE WOODLANDS, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at Citi's Biopharma Back to School Conference on Wednesday, September 3 at 1:45 …
Sarborg Limited Closes $10 Million Seed Round to Expand Proprietary Agentic Approach
GlobeNewswire
·
August 27, 2025
Funding supports next-generation AI agent development and proprietary Intellectual Property, focused initially on pharmaceutical drug-repurposing Initial clients reporting commercial success, revolutionizing indication selection of lead programs Early …
24/7 Market News: LIXTE Showcases LB-100 at First Global Conference on Oncogenic Signaling Activation as Cancer Therapy
GlobeNewswire
·
August 27, 2025
DENVER, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, highlights the publication of a new manuscript in Trends in Cancer (July 2025, …
Kailera Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity, today announced …
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
GlobeNewswire
·
August 27, 2025
DANBURY, Conn. and BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that United Therapeutics Corporation (Nasdaq: UTHR) has exercised its option—granted under the companies’ 2018 license and collaboration …
Cellectar Biosciences to Present Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
GlobeNewswire
·
August 27, 2025
FLORHAM PARK, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the acceptance …
24/7 Market News: Kraig Labs Prepares for High-Profile International Order as Second Production Facility Reaches Full Operational Status
GlobeNewswire
·
August 27, 2025
DENVER, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and insights, reports that Kraig Biocraft Laboratories (OTCQB: KBLB)(“Kraig Labs” or “the Company”), the …
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
GlobeNewswire
·
August 27, 2025
US Food and Drug Administration (FDA) has granted Fast Track designation for NRX-100 in the treatment of suicidal ideation in patients with depression, including bipolar depression. NRx Pharmaceuticals is making NRX-100 available on an expanded access …
Emergent BioSolutions to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences: Wells Fargo 20th Annual Healthcare …
Evaxion to present at several conferences during the second half of 2025
GlobeNewswire
·
August 27, 2025
Evaxion will provide scientific and company updates at numerous conferences in both the US, Europe and Asia during the coming months COPENHAGEN, Denmark, August 27, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company …
Aclaris Therapeutics to Participate in Two September Healthcare Conferences
GlobeNewswire
·
August 27, 2025
WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will …
Maxion Therapeutics Strengthens Board with Appointment of Dr. Santiago Arroyo as a Non-Executive Director
GlobeNewswire
·
August 27, 2025
Cambridge, UK, 27 August 2025 – Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel and G protein coupled receptor (GPCR)-driven diseases, today announces the appointment of Santiago Arroyo, PhD …
Annexon Biosciences to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 27, 2025
BRISBANE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
PHILADELPHIA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune …
IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
GlobeNewswire
·
August 27, 2025
AUSTIN, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire …